An Investigational Study of BG-89894 Tablets in Participants With Advanced Solid Tumors

NCT06568614 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped The study was discontinued following an internal decision by the sponsor

Conditions

Advanced or Metastatic MTAP-deleted Solid Tumors

Interventions

DRUG: BG-89894

Sponsor

BeOne Medicines